Two Diplopyrone Derivatives: Nitrile and Amide Compounds with Patented Biological Activity
Two novel derivatives of the natural compound diplopyrone—a nitrile and an amide—covered by a patent. These derivatives are designed to explore and expand the known biological activity of the parent natural product, offering potential applications in pharmaceutical and agrochemical research.
Overview
This offering comprises two novel chemical derivatives of diplopyrone, a natural compound with known biological activity. The two derivatives—a nitrile and an amide—are covered by a patent on which the inventor is named. Diplopyrone is a bioactive natural product, and these derivatives were synthesized to explore and potentially enhance its biological properties. By modifying the core structure, the derivatives may offer improved efficacy, selectivity, or novel applications compared to the parent compound.
These compounds are relevant to organizations interested in natural product-based drug discovery, agrochemical development, or the exploration of bioactive small molecules. The patented status of the derivatives provides a basis for licensing, co-development, or sponsored research partnerships.
Technical specifications
Key features:
- Two diplopyrone derivatives: a nitrile-functionalized variant and an amide-functionalized variant
- Based on a natural product scaffold with established biological activity
- Covered by a patent with the inventor listed as a named contributor
- Suitable for further biological evaluation, structure-activity relationship studies, and potential optimization
- Synthesized through targeted chemical modification of the parent diplopyrone compound
Potential applications:
- Pharmaceutical research and drug discovery based on natural product scaffolds
- Agrochemical development leveraging bioactive natural product derivatives
- Structure-activity relationship studies to guide further compound optimization
- Lead compound identification for therapeutic or crop protection programs
Technology readiness level
The derivatives have been synthesized and are covered by issued or pending patent protection. Further validation, including expanded biological testing and optimization studies, would be needed to advance these compounds toward commercial application. Interested partners can engage through licensing, co-development, or sponsored research arrangements to advance the evaluation and potential commercialization of these novel diplopyrone derivatives.
About University of Mississippi
A leading public research university in Mississippi, the University of Mississippi spans its main campus in Oxford and an academic medical center in Jackson, combining broad academic strength with a collaborative, service-oriented culture. Industry partners engage through a research and technology park that offers incubator space, shared core facilities, and collaboration suites next to campus. Integration with a major hospital system enables large-scale clinical research, access to clinical data, and translation from lab to care, while proximity to the Memphis logistics hub and regional manufacturing corridors shortens timelines from prototype to pilot. Research is supported by competitive federal funding, including awards from NIH, NSF, and the Department of Defense. A dedicated technology transfer office manages IP and licensing and supports startup formation within the park.
delivered to your inbox.